MicroRNAs as Novel Biomarkers for Breast Cancer

by H. M. Heneghan, N. Miller, A. J. Lowery, K. J. Sweeney, M. J. Kerin
Published 2010-01-01

Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis

by M.G. Davey, C.M. Davey, É.J. Ryan, A.J. Lowery, M.J. Kerin
Published 2021-04-01

Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis

by M.G. Davey, É.J. Ryan, M.R. Boland, M.K. Barry, A.J. Lowery, M.J. Kerin
Published 2021-08-01

Correction to: Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options

by Peter F. McAnena, Andrew McGuire, A. Ramli, C. Curran, C. Malone, R. McLaughlin, K. Barry, James A. L. Brown, M. J. Kerin
Published 2018-03-01

Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options

by Peter F. McAnena, Andrew McGuire, A. Ramli, C. Curran, C. Malone, R. McLaughlin, K. Barry, James A.L. Brown, M. J. Kerin
Published 2018-02-01

Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer

by M.C. Casey, A. Prakash, E. Holian, A. McGuire, O. Kalinina, A. Shalaby, C. Curran, M. Webber, G. Callagy, E. Bourke, M. J. Kerin, J. A. Brown
Published 2019-07-01

Investigating the association of rs2910164 with cancer predisposition in an Irish cohort

by T P McVeigh, R J Mulligan, U M McVeigh, P W Owens, M Bell, F Sebag, C Guerin, D S Quill, J B Weidhaas, M J Kerin, A J Lowery
Published 2017-10-01